Ready to play
Ready to play
Moderna and Merck announced that personalized cancer vaccines are nearing practical use. The companies are developing techniques to produce individualized vaccines that precisely target tumors, enhancing the chances of effective treatment and reducing side effects.
Notice: This Is an AI-Generated Summary
Comments (0)